Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1214717 BOSTON, MA

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$281,485,168
-$10,582,797 QoQ
Shares Held
2,136,672
+3.8% QoQ
Ownership
2.12%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.25926861961031.ToString("F0")% Shared 0.ToString("F0")% None 0.7407313803896902.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,626,668,708 across 67 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
2,136,672 $281,485,168

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $281,485,168 2,136,672
2025-12-31 $292,067,965 2,059,282
2025-09-30 $284,244,933 2,024,825
2025-06-30 $246,260,017 1,959,265
2025-03-31 $217,854,792 1,969,754
2024-12-31 $255,945,962 1,875,062
2024-09-30 $214,220,710 1,859,232
2024-06-30 $250,507,360 1,819,622
2024-03-31 $236,355,434 1,713,714
2023-12-31 $213,862,818 1,623,124
2023-09-30 $174,895,875 1,554,630
2023-06-30 $143,657,374 1,523,408
2023-03-31 $145,325,299 1,435,737
2022-12-31 $165,865,730 1,388,695
2022-09-30 $139,952,279 1,317,694
2022-06-30 $124,833,375 1,280,605
2022-03-31 $120,378,656 1,284,039
2021-12-31 $105,401,963 1,237,548
2021-09-30 $116,264,116 1,212,221
2021-06-30 $117,089,000 1,203,134
2021-03-31 $114,707,153 1,179,508
2020-12-31 $107,889,718 1,125,610
2020-09-30 $102,564,447 1,066,602
2020-06-30 $135,299,220 1,109,010
2020-03-31 $92,836,472 1,072,634